Precision medical equipment

Medical Device Manufacturing

By Abby Anaday on Unsplash

Medical Device Manufacturing

Country
Sector
Most major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Health Care
Sub Sector
Most major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Medical Technology
Indicative Return
Describes the rate of growth an investment is expected to generate within the IOA. The indicative return is identified for the IOA by establishing its Internal Rate of Return (IRR), Return of Investment (ROI) or Gross Profit Margin (GPM).
20% - 25% (in IRR)
Investment Timeframe
Describes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.
Short Term (0–5 years)
Market Size
Describes the value of potential addressable market of the IOA. The market size is identified for the IOA by establishing the value in USD, identifying the Compound Annual Growth Rate (CAGR) or providing a numeric unit critical to the IOA.
USD 100 million - USD 1 billion
Average Ticket Size (USD)
Describes the USD amount for a typical investment required in the IOA.
USD 1 million - USD 10 million
Direct Impact
Describes the primary SDG(s) the IOA addresses.
Responsible Consumption and Production (SDG 12) Industry, Innovation and Infrastructure (SDG 9) Gender Equality (SDG 5)
Indirect Impact
Describes the secondary SDG(s) the IOA addresses.
Decent Work and Economic Growth (SDG 8) Climate Action (SDG 13) Clean water and sanitation (SDG 6)

Business Model Description

Invest in B2B or B2C models engaged in manufacturing of medical devices or for scaling up an existing facility to cater to local and export demand. The medical devices could include Respirators, Monitors, Ventilators, and allied instruments, Personal Protection Equipment, Dental Veterinary Instruments and Appliances, Orthopedic Appliances, X-Rays, Radiography/ Radio Therapy Apparatus, Dialysis Machines and the like. Examples of active initiatives and companies in this space are:

GISD Alliance is a group of 30 high-powered business leaders from all over the world. In April 2021, Medical Device Development Centre was pitched by GOP to GISD Alliance for investment as a joint venture. Although local manufacturing is limited but can be scaled up as a necessary upgrade from the traditional surgical industry. (13)

PharmEvo, started in 1999, is a company in the business of developing, manufacturing and marketing high-quality products. Driven by its core values, PharmEvo has started Socially Responsible Marketing in Pakistan. With 20+ medical devices produced locally and other ventures in healthcare sector by PharmEvo, the company exports to 15 countries. (14)

Expected Impact

Increase penetration of healthcare delivery at by improving domestic manufacturing and distribution of medical devices and equipments.

How is this information gathered?

Investment opportunities with potential to contribute to sustainable development are based on country-level SDG Investor Maps.

Disclaimer

UNDP, the Private Finance for the SDGs, and their affiliates (collectively “UNDP”) do not seek or solicit investment for programmes, projects, or opportunities described on this site (collectively “Programmes”) or any other Programmes, and nothing on this page should constitute a solicitation for investment. The actors listed on this site are not partners of UNDP, and their inclusion should not be construed as an endorsement or recommendation by UNDP for any relationship or investment.

The descriptions on this page are provided for informational purposes only. Only companies and enterprises that appear under the case study tab have been validated and vetted through UNDP programmes such as the Growth Stage Impact Ventures (GSIV), Business Call to Action (BCtA), or through other UN agencies. Even then, under no circumstances should their appearance on this website be construed as an endorsement for any relationship or investment. UNDP assumes no liability for investment losses directly or indirectly resulting from recommendations made, implied, or inferred by its research. Likewise, UNDP assumes no claim to investment gains directly or indirectly resulting from trading profits, investment management, or advisory fees obtained by following investment recommendations made, implied, or inferred by its research.

Investment involves risk, and all investments should be made with the supervision of a professional investment manager or advisor. The materials on the website are not an offer to sell or a solicitation of an offer to buy any investment, security, or commodity, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction.

Read More

Country & Regions

Explore the country and target locations of the investment opportunity.
Country
Region
  • Pakistan: Punjab
  • Pakistan: Punjab
  • Pakistan: Punjab
Learn more

Sector Classification

Situate the investment opportunity within sustainability focused sector, subsector and industry classifications.
Sector

Health Care

Realizing the need to reduce poverty using Universal Health Cards (UHC), Government has increased spending on health sector in 2020 and 2021. As UHC uptake increases, demand for more hospitals and medical devices will also increase. Surgical instruments already contribute to Pakistan’s exports; thus, export of medical devices can also help in reducing the current account deficit. (1)

Policy priority
Pakistan Strategic Trade Policy Framework (STPF) 2020-2025 is a comprehensive document that narrows down sectors for trade and manufacturing in "developmental" and "traditional sectors". The policy proposes interventions as well as incentives to improve the surgical instrument, medical device and pharmaceutical sector and increase its export potential. (2)

Gender inequalities and marginalization issues
COVID-19 pandemic has exposed vulnerable populations disproportionately, severely affecting women's and girls’ health especially access to essential health services. (3) Due to floods 2022, 650,000 pregnant women faced challenges in getting access to maternal services, while nearly 4 million children lacked access to health services. (4)

Investment opportunities
There are 60 health sector projects in PSDP 22 to the tune of a total cost of USD 480 million. Total foreign funding share for health sector in this year’s PSDP FY22 is 4.4 percent, suggesting that the health sector will expand and create many opportunities for private sector investments. (5)

Key bottlenecks
Financing gap has remained one of the biggest bottlenecks in the growth of the sector as public sector expenditure has not reached its optimum levels. Currently, public sector expenditure is 1.2 percent of the GDP. (6) As per estimates, with 100 percent UHC, the gap is USD 3.1 Billion. (7)

Sub Sector

Medical Technology

Development need
As healthcare distribution includes sale, purchase of pharmaceutical products and medical equipment to hospitals, pharmacies, and physicians, the need for development of medical equipment industry is high. This need is driven largely by rates of insurance, pharmaceutical spending, illness, and demographics. (2)

Policy priority
Pakistan STPF 2020-2025 highlights manufacturing of medical devices as one of its priorities due to the high import cost of such devices and equipment. (6) In 2019, Pakistan imported USD 14 million worth of ventilators and USD 24 million worth of respiration apparatus. (8) The policy, therefore, recommends 'make in Pakistan' approach to reduce import bill and support the healthcare industry.

Gender inequalities and marginalization issues
Out of 13.5 million women that contribute 20 percent to the total workforce in Pakistan, jobs of ~50% of them are unpaid and unrecognized. (9) Furthermore, in Punjab, overall 44 percent employees are unregistered (2016) (10). Thus, it is difficult for such women and vulnerable employees to get equal wages, better employment contracts and training opportunities.

Investment opportunities
In terms of medical device manufacturing, the opportunity is products like Respirators, Monitors, Ventilators and allied instruments, Appliances, Orthopedic Appliances etc. In Pakistan, medical devices of such nature are imported and due to high cost of imports and from interventions proposed by STPF, devices are suggested to be developed in Pakistan. (11)

Key bottlenecks
In Pakistan, investors face regulatory risk (high compliance to regulations), lack of transparency, weak contract enforcement and difficulty finding reliable local partners. (12)

Industry

Medical Equipment and Supplies

Pipeline Opportunity

Discover the investment opportunity and its corresponding business model.
Investment Opportunity Area

Medical Device Manufacturing

Business Model

Invest in B2B or B2C models engaged in manufacturing of medical devices or for scaling up an existing facility to cater to local and export demand. The medical devices could include Respirators, Monitors, Ventilators, and allied instruments, Personal Protection Equipment, Dental Veterinary Instruments and Appliances, Orthopedic Appliances, X-Rays, Radiography/ Radio Therapy Apparatus, Dialysis Machines and the like. Examples of active initiatives and companies in this space are:

GISD Alliance is a group of 30 high-powered business leaders from all over the world. In April 2021, Medical Device Development Centre was pitched by GOP to GISD Alliance for investment as a joint venture. Although local manufacturing is limited but can be scaled up as a necessary upgrade from the traditional surgical industry. (13)

PharmEvo, started in 1999, is a company in the business of developing, manufacturing and marketing high-quality products. Driven by its core values, PharmEvo has started Socially Responsible Marketing in Pakistan. With 20+ medical devices produced locally and other ventures in healthcare sector by PharmEvo, the company exports to 15 countries. (14)

Business Case

Learn about the investment opportunity’s business metrics and market risks.

Market Size and Environment

Market Size (USD)
Describes the value in USD of a potential addressable market of the IOA.

USD 100 million - USD 1 billion

CAGR
Describes the historical or expected annual growth of revenues in the IOA market.

15% - 20%

Critical IOA Unit
Describes a complementary market sizing measure exemplifying the opportunities with the IOA.

The medical devices market in Pakistan is estimated at USD 500 - 600 million (15)

Market size for medical devices is estimated to be USD 500 - 600 million, growing at a CAGR of 15 percent during 2019 to 2023. The Government of Pakistan (GOP) spent about USD 785 million on healthcare during the fiscal year ending June 2021. (15)

Indicative Return

IRR
Describes an expected annual rate of growth of the IOA investment.

20% - 25%

The estimated IRR is based on a feasibility study for medical device development centers.

As per stakeholders in Punjab consultative session, Punjab's Sialkot Gujranwala cluster has skilled labor and basic technical capabilities for adding value to such businesses, and thereby generating a greater return of up to 25 percent IRR. (13)

Investment Timeframe

Timeframe
Describes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.

Short Term (0–5 years)

As per experts' consultations with Healthcare Device Association of Pakistan (HDAP), two years' time frame (year one construction and year two operations) is required to break-even in a medical device manufacturing business.

Pakistan's medical devices market is expected to grow at 5 percent CAGR during 2019-2023. (15)The global medical devices market is projected to grow from USD 495.46 billion in 2022 to USD 718.92 billion in 2029, at a CAGR of 5.5 percent during 2022-2029. (16)

Ticket Size

Average Ticket Size (USD)
Describes the USD amount for a typical investment required in the IOA.

USD 1 million - USD 10 million

Market Risks & Scale Obstacles

Capital - Limited Investor Interest

In terms of the sector’s linkages with the GVCs, 98 percent of local participation is concentrated in the precision metal instruments segment. Resultantly, leading firms (MNEs) dominate the global medical devices business have not actively invested in Pakistan’s domestic industry. (17)

Market - High Level of Competition

Only 3-4 percent of total companies are manufacturing locally and earning up to 25 percent returns. However, the level of competition is intense, especially with companies that import devices and distribute in the local market.

Impact Case

Read about impact metrics and social and environmental risks of the investment opportunity.

Sustainable Development Need

Medical device disposal is a significant issue in Pakistan; generally carried out through incineration in the EU, it typically releases nitrous oxide, as well as known carcinogens including polychlorinated biphenyls, furans and dioxins. Some of the strategies implemented by manufacturers to reduce waste matter destined to incineration include sterilization and reprocessing.

The need is to orient the design of devices on creating a simple, repeatable interface between two component sections to improve functionality or efficacy. As reducing waste and harmful emissions continues to exert businesses and governments globally, the medical devices industry can also contribute.

Effective environmental sustainability in the sector cannot exist without a full view of product life cycle from development, material selection, design, engineering to manufacturing, packaging, transportation, sales, use, and end-of-life disposal. (18)

Gender & Marginalisation

Traditionally women in Pakistan have restricted access to medical and health facilities, increasing their risk of diseases and illnesses. Issues that constrain women's access to healthcare services range from limited autonomy in households, lack of participation in financial decision-making, social disapproval of unassisted travel and long travel time to access medical facilities.

In the healthcare sector, there is also a "motherhood gap" where there is an increase in part-time employment among women of child-rearing age in Pakistan. The gender pay gap increases significantly at ages when women and men begin having children. (18)  

There is a need to increase job opportunities for women within the healthcare sector, especially in higher positions and to present them with better and more flexible contracts. As of 2021, men dominate all top positions, while women take up part-time work in the sector. Overall, as of 2021, women constitute only 23.3 per cent of the workforce. (19)

In Pakistan, men are overrepresented in the healthcare profession and in semi-/low-skilled non-health fields. Women are more likely than men to occupy semi-/low-skilled healthcare related jobs such as playing the role of support and personal health and care workers and their representation in this semi/low-skilled space is 15 per cent or more than that of men (19) 

Expected Development Outcome

With development of aftersales services and repairs, sustainable solutions like reuse and recycle can be introduced.

With adequate protective gear for workers, air and water treatment plants installed in the manufacturing units and centers, investments can be made sustainable.

Gender & Marginalisation

Healthcare sector and specifically, the IOA have a dual impact on gender equality as it can contribute to generating improved job opportunities for women and promise them increased access to medical facilities.

Primary SDGs addressed

Responsible Consumption and Production (SDG 12)
12 - Responsible Consumption and Production

12.4.2 (a) Hazardous waste generated per capita; and (b) proportion of hazardous waste treated, by type of treatment

Current Value

In 2015, Pakistan was party to four international agreements on hazardous waste. From 2015 to 2020 on two agreements country's performance was 100% while the performance decreased to 25 percent from 50 percent in Stokholm and improved in Rotterdam convention to 70 percent from 64 percent. (20)

Target Value

The target levels of compliance of four conventions on hazardous waste was set at 100% compliance. (Rotterdam, Stockholm, Montreal Protocol and Basel Convention) (20)

Industry, Innovation and Infrastructure (SDG 9)
9 - Industry, Innovation and Infrastructure

9.2.1 Manufacturing value added as a proportion of GDP and per capita

9.3.1 Proportion of small-scale industries in total industry value added

Current Value

On SDG 9 manufacturing value added (MVA) as a proportion of GDP slightly reduced to 12.23 from 13.56 percent between 2015-20 at the national level. Though MVA declined, manufacturing employment as a proportion of total employment remain unchanged at 15 percent during 2015-19 at the national level. This proportion significantly decreased by 7% in Balochistan from 11 to 4 percent during 2015-19. (20)

The proportion of small-scale industries in total industry value added increased to 10.50% in 2019-20 from 8.40 percent in 2014-15, despite the overall negative effects of COVID-19 in 2019-20. (20)

Target Value

The national vision 2025 and voluntary national review, strategic trade policy framework considers increase of value-added manufacturing important for Goal 9 but do not provide a specific quantifiable target. (21)

The national vision 2025 and Strategic Trade Policy and Voluntary National Review consider increase in small scale industry proportion as an important metric of development but do not provide a specific quantifiable target. (21)

Gender Equality (SDG 5)
5 - Gender Equality

5.5.2 Proportion of women in managerial positions

Current Value

The percentage of women in managerial positions has increased from 2.70 percent (2014) 4.53 percent in 2019. (20)

Target Value

The National Vision 2025 by Government sets the target of increasing women labor force participation from 24 to 45 percent by 2025 but does not give a specific target of increasing their presence in managerial positions. (21)

Secondary SDGs addressed

Decent Work and Economic Growth (SDG 8)
8 - Decent Work and Economic Growth
Climate Action (SDG 13)
13 - Climate Action
Clean water and sanitation (SDG 6)
6 - Clean water and sanitation

Directly impacted stakeholders

People

People in general will benefit by accessible, affordable medical procedures.

Gender inequality and/or marginalization

Through IOA not only women get better job opportunities but also get benefit from affordable medical procedures.

Planet

Improved waste management techniques, longer-life of medical devices and after sales service, protect the environment, both in terms of production as well as consumption.

Corporates

Hospitals, suppliers of raw materials, devices distributors and exporters benefit as part of health care value chain in the domestic market due to reduced prices of medical equipment and appliances.

Public sector

Public sector: Drug Regulatory Authority of Pakistan as Medical Devices also come under their purview, Ministry of Industries, Health and Industries dept of all provincial governments benefit from increased revenue collection and better investment climate.

Indirectly impacted stakeholders

People

Skilled and unskilled workers benefit from better employment opportunities and trainings in new technologies which will improve their employment contracts.

Gender inequality and/or marginalization

Due to affordable medical procedures, women have more at hand to spend on other essentials like education.

Corporates

Buyers in the global value chain, as well as material or device component suppliers of devices, will benefit from increased production of medical devices.

Public sector

Good health and well-being of the public is ensured with the availability of affordable and accessible surgical and other lifesaving medical devices. Increased revenues from domestic production and consumption, as well as exporting to Global value chain benefits the economy.

Outcome Risks

Absence of regulations may encourage malpractices such as underpayment to employees, poor working conditions, among others.

Absence of regulations may still exclude women from obtaining gainful job opportunities with the right remuneration.

Unless manufacturing units achieve economies of scale, they will not be able to compete with low-cost imported products.

Impact Risks

Impact of reuse and recycling may not be clearly seen or adopted if business model does not have a recycling unit and offers after sale services.

There is a risk of exclusion if issues that hinder women's participation like transport, safe environment and flexible contracts are not addressed.

Impact Classification

C—Contribute to Solutions

What

Affordable healthcare equipment reduces the cost of healthcare delivery thereby making it accessible to underserved communities.

Who

The IOA impacts the existing cluster in Sialkot and gives an opportunity to manufacturers of medical devices to generate higher revenues.

Risk

Unless manufacturing units achieve economies of scale, they will not be able to compete with low-cost imported products.

Contribution

The business model contributes to reduced cost of surgeries, diagnostics and medica l procedures hence reducing health expenditure.

How Much

Expected yet gradual import substitution from imported medical equipment and devices market of USD 500 million. (22)

Impact Thesis

Increase penetration of healthcare delivery at by improving domestic manufacturing and distribution of medical devices and equipments.

Enabling Environment

Explore policy, regulatory and financial factors relevant for the investment opportunity.

Policy Environment

Strategic Trade Policy Framework (STPF) 2020-2025: The framework suggests incentives and Interventions specific to medical devices, and pharmaceuticals as a sector requiring development efforts. A special recommendation proposed is to increase in labor and enterprise productivity. (6)

The framework has already resulted in the completion of intervention regarding training in technology upgradation and its capacity building, enhanced market access, innovation-driven exports, product diversification and value addition. (6)

Financial Environment

Financial incentives: Refinance Scheme for Working Capital Financing of Small Enterprises and Low-End Medium Enterprises. A credit equal to 100% of the investment may be available to both Pakistani and foreign investors when the minimum investment is at least USD 175,000.

In case of special economic zone: Exemption from income tax for ten years for Zone Developers, Co-developers and Zone Enterprises and One time exemption from all custom-duties and taxes on import of capital goods to Zone Developers, Co-developers and Zone Enterprises. (24)

Regulatory Environment

Medical Device Rules by Drug Regulatory Authority of Pakistan, state the registration process of medical devices as well as the relevant processes to import medical devices to Pakistan. (23)

The European Union Medical Device Regulation (MDR)/Regulation (EU) 2017/745 (EU MDR) entered into force on 26th May 2021, impacting manufactures which were previously exempt from medical device regulation. The new regulations will be fully implemented from May 2024.

Marketplace Participants

Discover examples of public and private stakeholders active in this investment opportunity that were identified through secondary research and consultations.

Private Sector

Corporates: PharmEvo, Alison and Surgicon limited Investors: Evercare, JS Bank, Cordoba Ventures, Glowfish Capital in Heath care "

Government

Drug Regulatory Authority of Pakistan and Ministry of National Health Sciences, Reseach and Coordination

Multilaterals

International Labor organization, Asian Development Bank, World Bank, Islamic Development Bank

Non-Profit

Healthcare Device Association of Pakistan, Surgical Instrument Manufacturing Association of Pakistan, Overseas Chambers, Federal and Provincial Chambers of Commerce and Industries.

Target Locations

See what country regions are most suitable for the investment opportunity. All references to Kosovo shall be understood to be in the context of the Security Council Resolution 1244 (1999)
country static map
urban

Pakistan: Punjab

Punjab, Sialkot: basic skills, material, machinery is present. With right investments and upgradation, the traditional surgical instrument sector can be enhanced and upgraded to medical devices. (25)
urban

Pakistan: Punjab

Punjab, Lahore: Although Sialkot is the main cluster, but closer in vicinity and with skilled labor and presence of investors, Lahore can also be a suitable location. (25)
urban

Pakistan: Punjab

Punjab, Gujranwala: Gujranwala is the cluster of light engineering manufacturers and has similar characteristics as that of Sialkot. (25)

References

See what sources were used to establish the investment opportunity’s data and find resources that could be consulted to explore more.